Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Terrone

Showing results (221-230 of 338) with videos related to

Pageof 34
Sort By:
The Prostate|June 2, 2022
Rates of metastatic prostate cancer in newly diagnosed patients: Numbers needed to image according to risk levelGabriele Sorce, Benedikt Hoeh, Rocco S Flammia, et al.
International Urology and Nephrology|May 4, 2022
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicityFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
The Prostate|February 21, 2022
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groupsBenedikt Hoeh, Christoph Würnschimmel, Rocco Simone Flammia, et al.
The Prostate|February 21, 2022
Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patientsBenedikt Hoeh, Rocco S Flammia, Lukas Hohenhorst, et al.
Central European Journal of Urology|July 24, 2023
The association of the type and number of D'Amico high-risk criteria with rates of pathologically non-organ-confined prostate cancerFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.
The Prostate|April 2, 2022
Grade and stage misclassification in intermediate unfavorable-risk prostate cancer radiotherapy candidatesGabriele Sorce, Rocco Simone Flammia, Benedikt Hoeh, et al.
Clinical Genitourinary Cancer|December 3, 2014
A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: the RECORd1 Italian ProjectRiccardo Schiavina, Sergio Serni, Andrea Mari, et al.
The Prostate|March 15, 2023
The association of type and number of high-risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapyFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.
International Urology and Nephrology|July 15, 2022
Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patientsRocco S Flammia, Benedikt Hoeh, Lukas Hohenhorst, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 2, 2022
Prediction of significant renal function decline after open, laparoscopic, and robotic partial nephrectomy: External validation of the Martini's nomogram on the RECORD2 project cohortAlessandro Antonelli, Andrea Mari, Alessandro Tafuri, et al.
Pageof 34

Showing results (221-230 of 338) with videos related to

Sort By:
Pageof 34
The Prostate|June 2, 2022
Rates of metastatic prostate cancer in newly diagnosed patients: Numbers needed to image according to risk levelGabriele Sorce, Benedikt Hoeh, Rocco S Flammia, et al.
International Urology and Nephrology|May 4, 2022
Life expectancy in metastatic urothelial bladder cancer patients according to race/ethnicityFrancesco Chierigo, Marco Borghesi, Christoph Würnschimmel, et al.
The Prostate|February 21, 2022
Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groupsBenedikt Hoeh, Christoph Würnschimmel, Rocco Simone Flammia, et al.
The Prostate|February 21, 2022
Non-organ confined stage and upgrading rates in exclusive PSA high-risk prostate cancer patientsBenedikt Hoeh, Rocco S Flammia, Lukas Hohenhorst, et al.
Central European Journal of Urology|July 24, 2023
The association of the type and number of D'Amico high-risk criteria with rates of pathologically non-organ-confined prostate cancerFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.
The Prostate|April 2, 2022
Grade and stage misclassification in intermediate unfavorable-risk prostate cancer radiotherapy candidatesGabriele Sorce, Rocco Simone Flammia, Benedikt Hoeh, et al.
Clinical Genitourinary Cancer|December 3, 2014
A prospective, multicenter evaluation of predictive factors for positive surgical margins after nephron-sparing surgery for renal cell carcinoma: the RECORd1 Italian ProjectRiccardo Schiavina, Sergio Serni, Andrea Mari, et al.
The Prostate|March 15, 2023
The association of type and number of high-risk criteria with cancer specific mortality in prostate cancer patients treated with radiotherapyFrancesco Chierigo, Rocco Simone Flammia, Gabriele Sorce, et al.
International Urology and Nephrology|July 15, 2022
Adverse upgrading and/or upstaging in contemporary low-risk prostate cancer patientsRocco S Flammia, Benedikt Hoeh, Lukas Hohenhorst, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|March 2, 2022
Prediction of significant renal function decline after open, laparoscopic, and robotic partial nephrectomy: External validation of the Martini's nomogram on the RECORD2 project cohortAlessandro Antonelli, Andrea Mari, Alessandro Tafuri, et al.
Pageof 34